Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.
D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001921:Brain / Q000378:metabolism; D002110:Caffeine / Q000494:pharmacology*; D002230:Carbidopa / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008124:Locomotion / Q000187:drug effects*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D011941:Receptors, Adrenergic / Q000187:drug effects*; D012701:Serotonin / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D011941:Receptors, Adrenergic; D014316:Tritium; D012701:Serotonin; D002110:Caffeine; D014443:Tyrosine; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D002230:Carbidopa; D004298:Dopamine; D009638:Norepinephrine